View Cart  

Pfizer’s Orphan Leukemia Drug Wins FDA Approval

A A
The FDA has OKed Pfizer’s Bosulif, a once-daily pill to treat chronic myelogenous leukemia (CML), marking the pharma giant’s third new oncology drug approval in a little more than a year.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00